Erratum: Corrigendum: mTORC1-dependent AMD1 regulation sustains polyamine metabolism in prostate cancer
Amaia Zabala‐Letona(BioCruces Health research Institute), Javier Muñoz(Ikerbasque), Rosa Farrás(Centro de Investigacion Principe Felipe), Alfredo Caro‐Maldonado(CIC bioGUNE), Ana R. Cortázar(CIC bioGUNE), Verónica Torrano(University of the Basque Country), Ludmila Prudkin, José Jimenez(Molecular Oncology (United States)), Gina Lein(Agios Pharmaceuticals (United States)), Ines Torres(Universitat Autònoma de Barcelona), Julen Tomás‐Cortázar(CIC bioGUNE), Marco Piva(CIC bioGUNE), Pilar Ximénez‐Embún(Spanish National Cancer Research Centre), Itziar Fernández-Domínguez(CIC bioGUNE), David Pirman(Pfizer (United States)), Isabel Lacasa-Viscasillas(Hospital de Basurto), Lorea Valcárcel-Jiménez(Tisch Hospital), Leire Arreal(CIC bioGUNE), Félix Elortza(CIC bioGUNE), Pilar Sánchez‐Mosquera(CIC bioGUNE), Alejo Efeyan(Spanish National Cancer Research Centre), Naiara Beraza(Quadram Institute), Amelia Barnett(Agios Pharmaceuticals (United States)), Ylenia Cendón(Spanish National Cancer Research Centre), Patricia Zúñiga-García(CIC bioGUNE), Diana Cabrera(CIC bioGUNE), Michelle Clasquin(Agios Pharmaceuticals (United States)), David Olmos(Spanish National Cancer Research Centre), Natalia Martín-Martín(CIC bioGUNE), Violeta Serra(Vall d'Hebron Institute of Oncology), James D. Sutherland(CIC bioGUNE), George Thomas(Oregon Health & Science University), Antonio Gentilella(Institut d'Investigació Biomédica de Bellvitge), Sebastiaan van Liempd(CIC bioGUNE), Ružica Bago(MRC Protein Phosphorylation and Ubiquitylation Unit), Sonia Fernández‐Ruiz(CIC bioGUNE), Elena Castro(Research Institute Hospital 12 de Octubre), Mikel Azkargorta(Instituto de Salud Carlos III), Andrea Alimonti(Veneto Institute of Molecular Medicine), Ianire Astobiza(University of the Basque Country), Mireia Castillo-Martín(Champalimaud Foundation), Juan Anguíta(Ikerbasque), Miguel Unda(Hospital de Basurto), Aitziber Ugalde‐Olano(Hospital de Basurto), Yinan Zhang(Hangzhou Normal University), Stuart Murray(Agios Pharmaceuticals (United States)), Phong Quang(Agios Pharmaceuticals (United States)), Amaia Arruabarrena-Aristorena(CIC bioGUNE), Ana Loizaga‐Iriarte(Hospital de Basurto), Ajinkya Revandkar(Harvard University)
Cited by 5
Related Papers
mTOR: from growth signal integration to cancer, diabetes and ageing
|Nature Reviews Molecular Cell Biology|2010|4k
mTORC1 Senses Lysosomal Amino Acids Through an Inside-Out Mechanism That Requires the Vacuolar H <sup>+</sup> -ATPase
|Science|2011|1.6k
Senescence in premalignant tumours
|Nature|2005|1.5k
Cellular Senescence: Aging, Cancer, and Injury
|Physiological Reviews|2019|1.3k
Nutrient-sensing mechanisms and pathways
|Nature|2015|1.1k